A manufacturing-systems practitioner who started on the production line.
biograph was founded by James Bellars — over 25 years in pharmaceutical manufacturing operations. Production floor to enterprise architecture, across four MES platforms, forty-plus sites, and £160M+ of delivered programme value. The arc below is the practice before it was a practice.
Twenty-five years inside the programmes.
Every programme started by trying to reconstruct what already existed — from scratch, manually, incompletely. The same pattern, at every site.
James started on the production line at GSK in 2001 and moved through supervisory and validation roles, understanding manufacturing systems from the operations side before moving into systems architecture.
He became Enterprise Architect for manufacturing systems across 40+ global sites at GSK, where he led the architecture for GSK's Bio-Pharm new build — rated "best in class" by the MHRA.
Over the following years, he delivered £160M+ in MES programmes across 15+ sites at companies including AstraZeneca, Novo Nordisk, Pfizer, Novartis, and others — spanning system selection, tech transfer, multi-site deployment, and enterprise integration architecture.
He led the MES integration workstream on the GSK Consumer Health M&A programme — integrating acquired Pfizer sites into the GSK network as part of the transition that ultimately created Haleon — and subsequently supported the new company's expansion of MES across several sites.
The same observation, at every scale.
Started on the production line.
Walked onto the shop floor at a GSK manufacturing facility and began learning how pharmaceutical operations actually work — not from architecture diagrams, but from the process itself. Batch records, SOPs, equipment changeovers. The daily reality of making medicines under regulatory scrutiny.
Moved through supervisory and validation roles.
Understanding manufacturing systems from the operations side — computerised system validation, equipment qualification, change control — before moving into systems architecture. The first view of how specification and implementation drift apart.
Manufacturing systems across 40+ global sites.
Enterprise Architect for manufacturing systems across more than forty global sites at GSK. Four different MES platforms, each with its own data model, each integrated with SAP, each serving a different part of the estate.
Architecture for the Bio-Pharm new build — best in class.
Led the architecture for GSK's Bio-Pharm new build — an end-to-end digital facility the MHRA rated "best in class" on record, for process-control discipline.
MES integration on the M&A that became Haleon.
Led the MES integration workstream on the GSK Consumer Health M&A programme — integrating acquired Pfizer sites into the GSK network as part of the transition that ultimately created Haleon — and subsequently supported the new company's expansion of MES across several sites.
£160M+ in MES programmes across 15+ sites.
Delivered £160M+ in MES programmes across 15+ sites at companies including AstraZeneca, Novo Nordisk, Pfizer, Novartis, and others — spanning system selection, tech transfer, multi-site deployment, and enterprise integration architecture.
Built the framework the programmes kept asking for.
Biograph exists because that gap should not require a six-month consulting engagement to close. It should be a capability.
Recognise the pattern in your programme? Open a conversation.